Skip to main content
Medartis Holding AG logo

Medartis Holding AG — Investor Relations & Filings

Ticker · MED ISIN · CH0386200239 LEI · 506700VUSP6HG3F28846 SW Manufacturing
Open in API
Filings indexed 101 across all filing types
Latest filing 2023-03-09 Annual Report
Country CH Switzerland
Listing SW MED

About Medartis Holding AG

https://www.medartis.com/

Medartis Holding AG is a medical device company that develops, manufactures, and distributes implant solutions for the surgical fixation of bone fractures. The company provides precision-engineered system solutions, including titanium screws, plates, and surgical instruments. Its primary focus is on osteosynthesis for the upper and lower extremities, as well as for cranio-maxillofacial surgery. Medartis offers comprehensive solutions designed to support surgeons and facilitate optimal patient care in fracture fixation procedures.

Recent filings

Filing Released Lang Actions
Annual Report 2022
Annual Report Classification · 100% confidence The document is a comprehensive annual report for Medartis for the fiscal year 2022. It includes a table of contents referencing sections such as 'Message from the Chairman', 'Business Review', 'Corporate Governance Report', 'Remuneration Report', and 'Financial Report'. It contains detailed financial tables, performance indicators, and business strategy descriptions. It is clearly a full-year annual report rather than a short announcement or a specific subset like an earnings release. FY 2022
2023-03-09 English
Medartis 2022 full-year results presentation
Report Publication Announcement Classification · 99% confidence The document is titled "Medartis 2022 full-year results presentation" and is an invitation for a webcast scheduled for March 14, 2023, to discuss the FY 2022 results. It explicitly states that several documents will be published concurrently: (a) Press Release, (b) the 2022 Annual Report, (c) Sustainability Report, and (d) the Conference Presentation. Since the document itself is an announcement inviting users to an event where these reports will be released, and its length is relatively short (4381 chars), it fits the definition of a Report Publication Announcement (RPA) rather than the full reports themselves (like 10-K or ER).
2023-02-16 English
Medartis 2022 full-year results presentation
Report Publication Announcement Classification · 98% confidence The document is an invitation and announcement regarding the upcoming release of several reports (2022 Annual Report, Sustainability Report, Press Release) and a scheduled webcast/conference call for discussing the FY 2022 results. It explicitly states that the documents 'will be published' on a specific date (14 March 2023) and provides details for the associated conference call. Since the document itself is not the full Annual Report (10-K) or the full Conference Transcript (CT), but rather an announcement about the publication of these items and the associated event, it fits best under Report Publication Announcement (RPA). The document length (3879 chars) is also relatively short, supporting the 'announcement' classification over the full report classification.
2023-02-16 English
Veröffentlichung Geschäftsergebnisse 2022
Report Publication Announcement Classification · 98% confidence The document is a short announcement (under 5,000 characters) dated February 16, 2023, titled "Veröffentlichung Geschäftsergebnisse 2022" (Publication of 2022 Business Results). It explicitly states that the company will publish several documents, including the press release, the annual report ('Geschäftsbericht'), the sustainability report, and the conference presentation, on March 14, 2023, and invites recipients to a Webcast/Q&A session. According to Rule #2 (The 'MENU VS MEAL' Rule), when a document is short and announces the publication of other reports (like the Annual Report or Sustainability Report), it should be classified as a Report Publication Announcement (RPA).
2023-02-16 German
Medartis reports 20% sales growth and makes further progress in strengthening its US organisation
Earnings Release Classification · 100% confidence The document is explicitly titled as an 'Ad-hoc' announcement released on '16 August 2022' and contains the key phrase 'Release of an ad hoc announcement pursuant to Art. 53 LR.' It details 'Half Year 2022 key financials,' including net sales, gross profit, and EBITDA for H1 2022 compared to H1 2021. The content is a comprehensive summary of financial performance for a period shorter than a year (six months). This strongly indicates an Interim/Quarterly Report disclosure, which corresponds to the 'Interim / Quarterly Report' definition (Code: IR). It is not a full Annual Report (10-K), a brief Earnings Release (ER), or a mere announcement of a report (RPA). H1 2022
2022-08-16 English
Medartis reports 20% sales growth and makes further progress in strengthening its US organisation
Earnings Release Classification · 100% confidence The document explicitly states it is an 'Ad hoc announcement pursuant to Art. 53 LR' and reports on 'Half Year 2022 key financials'. It details sales growth, regional performance, and financial metrics (Net Sales, Gross profit, EBITDA) for the first half of the year (H1 2022). This content structure—a summary of financial performance for a period shorter than a full year—is characteristic of an Interim/Quarterly Report. Although it is presented as an 'ad hoc announcement', the core content is the comprehensive half-year financial review, making 'Interim / Quarterly Report' (IR) the most accurate classification over a simple 'Earnings Release' (ER) or 'Report Publication Announcement' (RPA), given its length and detail. H1 2022
2022-08-16 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.